News Releases

scPharmaceuticals Inc. to Present at the 8th Annual SVB Leerink Partners Global Healthcare Conference
BURLINGTON, Mass. , Feb. 21, 2019 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today[…]
scPharmaceuticals Inc. Announces Development Agreement with West Pharmaceutical Services for Next-Generation FUROSCIX® On-Body Infusor
Advancing FUROSCIX ® with the SmartDose ® Drug Delivery System Forecast 2018 year-end cash of $82 - $87 million and 2019 expenditures of  $8 - $10 million per quarter BURLINGTON, Mass. , Jan. 29, 2019 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on[…]